Hepatitis B Virus Testing MarketPosted by ahila on April 24th, 2018 Hepatitis B is a liver disease caused by the Hepatitis B virus (HBV). Hepatitis B viral infection ranges can form mild infection which last few weeks and a chronic infection that may lead to liver disorders and even death. Hepatitis B is one of the global health problem. Hepatitis B can cause chronic infection and puts people at high risk of death from cirrhosis and liver cancer. The virus is transmitted through contact with the blood or other body fluids of an infected person. According to World Health Organization, 257 Mn people are living with hepatitis B virus infection worldwide and in 2015, 887 000 hepatitis B resulted deaths. Increase in liver cancer cases, growing aging population, healthcare spending and urbanization. leading to better monitoring and screening procedures. In addition, government initiatives in growing awareness in public, increase in R&D spending by companies and growing demand for bio marker tests due to its accuracy expected to boost the hepatitis B virus testing market during the forecast period. However, factors such as lack of awareness in developing countries, stringent regulatory rules, rigid competition and high cost of testing are expected to hamper the hepatitis B virus testing market over the forecast period. A sample of this report is available upon request @ The global hepatitis B testing market is classified on the basis of test type, technique end use, and geography. Based on test type, the global hepatitis B diagnostic test market is segmented into the following:
Based on techniques, the global hepatitis B diagnostic test market is segmented into the following:
Based on end-user type, the global hepatitis B diagnostic test market is segmented into the following:
To view TOC of this report is available upon request @ Like it? Share it! More by this author |